BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19368933)

  • 21. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
    Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
    Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
    Xu YH; Lu S
    Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival.
    Skjefstad K; Richardsen E; Donnem T; Andersen S; Kiselev Y; Grindstad T; Hald SM; Al-Shibli K; Bremnes RM; Busund LT; Al-Saad S
    Steroids; 2015 Jun; 98():29-36. PubMed ID: 25668612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
    Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.
    Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
    Am J Clin Pathol; 2012 Aug; 138(2):230-5. PubMed ID: 22904134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
    Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E
    Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
    Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
    J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.
    Dalquen P; Sauter G; Torhorst J; Schultheiss E; Jordan P; Lehmann S; Solèr M; Stulz P; Mihatsch MJ; Gudat F
    J Pathol; 1996 Jan; 178(1):53-8. PubMed ID: 8778317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between morphometry and immunostaining of malignant cells in non-small cell lung cancer.
    Politi EN; Lazaris AC; Kavantzas N; Koutselini H
    Anal Quant Cytol Histol; 2003 Jun; 25(3):169-76. PubMed ID: 12882088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
    Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
    J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease.
    Garcia-Lujan R; Conde-Gallego E; Lopez-Ríos F; Martin de Nicolas JL; Sanchez-Céspedes M; García-Quero C; Echave-Sustaeta JM; Lopez-Encuentra A
    Histol Histopathol; 2009 Apr; 24(4):417-23. PubMed ID: 19224444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression.
    Kohri T; Sugano M; Kawashima O; Saito R; Sakurai S; Sano T; Nakajima T
    Surg Today; 2006; 36(12):1039-46. PubMed ID: 17123130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].
    Ucvet A; Kul C; Gursoy S; Erbaycu AE; Kaya SO; Dinc ZA; Yucel N
    Arch Bronconeumol; 2011 Aug; 47(8):397-402. PubMed ID: 21696876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.